We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
The 13th European Life Sciences CEO Forum is a global bio-pharma industry event that effectively brings into focus pivotal challenges and opportunities for this year in investment, partnering and alliance management. Within a series of planels major industry players will share their insights on the overall picture and breakthroughs in different therapeutic areas.
Please, contact us to arrange a meeting with OCT Clinical team and discuss your trial options.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.